Перейти к содержанию

Medline Inc. (MDLN) stock: revenue, earnings & dividend

Medline Inc. (MDLN, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener MDLN · Nasdaq Medizintechnik & Messgeräte US-IL

Key figures

Fiscal year
2025
Revenue
28.4 bn $
Revenue growth
11.5 %
Revenue growth 5y (p.a.)
–
Net income
1.16 tn $
Net margin
4,069.4 %
Operating margin
7.8 %
Earnings per share (diluted)
-0.01 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
38.5 bn $
Equity
10.7 bn $
Equity ratio
27.9 %
Return on equity
10,775.8 %
Cash
1.94 bn $
Operating cash flow
1.74 bn $
Free cash flow
1.3 bn $
Shares outstanding
–

History

Revenue by fiscal year

2023 23.2 bn $
2024 25.5 bn $
2025 28.4 bn $

Net income by fiscal year

2025 1.16 tn $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202528.4 bn $1.16 tn $-0.01 $–1.74 bn $
202425.5 bn $–––1.77 bn $
202323.2 bn $–––1.69 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)